Coherus BioSciences, Inc. markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor. Pipeline products include biosimilars of Humira, Avastin, and Lucentis. Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China.
Market Cap | 458.89 Million | Shares Outstanding | 77.778 Million | Avg 30-day Volume | 1.297 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.65 |
Price to Revenue | 3.6876 | Debt to Equity | 4.1778 | EBITDA | -256.43 Million |
Price to Book Value | 12.322 | Operating Margin | -80.8015 | Enterprise Value | 1.195 Billion |
Current Ratio | 3.643 | EPS Growth | -3.352 | Quick Ratio | 3.268 |
1 Yr BETA | 1.5747 | 52-week High/Low | 14.11 / 5.58 | Profit Margin | -87.9189 |
Operating Cash Flow Growth | -124.2836 | Altman Z-Score | -0.9518 | Free Cash Flow to Firm | -129.673 Million |
Earnings Report | 2023-05-04 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
LANFEAR DENNIS M PRESIDENT & CEO |
|
1,174,502 | 2023-01-20 | 3 |
VEXLER VLADIMIR CHIEF SCIENTIFIC OFFICER |
|
131,323 | 2023-01-20 | 4 |
STILWELL MCDAVID CHIEF FINANCIAL OFFICER |
|
104,243 | 2023-01-20 | 3 |
MCMICHAEL BRYAN J SEE REMARKS |
|
26,386 | 2023-01-20 | 5 |
|
0 | 2022-05-18 | 2 | |
|
0 | 2022-05-04 | 3 | |
|
40,000 | 2022-02-25 | 0 | |
|
0 | 2022-02-02 | 0 | |
|
27,000 | 2022-01-07 | 0 | |
|
27,000 | 2022-01-07 | 0 | |
|
27,000 | 2022-01-07 | 0 | |
ANICETTI VINCENT R CHIEF OPERATING OFFICER |
|
274,790 | 2021-07-06 | 0 |
|
20,000 | 2021-05-21 | 0 | |
VIRET JEAN-FREDERIC CHIEF FINANCIAL OFFICER |
|
61,295 | 2021-02-01 | 0 |
|
0 | 2021-01-11 | 0 | |
|
0 | 2021-01-11 | 0 | |
|
0 | 2021-01-11 | 0 | |
|
0 | 2020-01-10 | 0 | |
|
0 | 2020-01-10 | 0 | |
V-SCIENCES INVESTMENTS PTE LTD |
|
7,381,116 | 2019-12-30 | 0 |
HORTON DARLENE P SEE REMARKS |
|
0 | 2019-01-18 | 0 |
FINCK BARBARA K CHIEF MEDICAL OFFICER |
|
37,043 | 2018-09-10 | 0 |
|
1,940,914 | 2018-02-01 | 0 | |
WATLER PETER K. CHIEF TECHNICAL OFFICER |
|
5,900 | 2018-02-01 | 0 |
HERMAN ALAN C. CHIEF SCIENTIFIC OFFICER |
|
350,624 | 2017-12-15 | 0 |
|
No longer subject to file | 2016-08-08 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
5,893,736 | 2012-03-27 | 0 | |
|
59,785 | 2010-10-15 | 0 | |
ROMANO ANTHONY EVP - CHIEF OPERATING OFFICER |
|
40,637 | 2010-10-15 | 0 |
FOGARTY JAMES P PRESIDENT AND CEO |
|
125,000 | 2010-06-24 | 0 |
LEVITT JAY PRESIDENT - FASHION BUG |
|
42,331 | 2010-06-08 | 0 |
|
18,000 | 2010-04-07 | 0 | |
|
98,195 | 2009-07-01 | 0 | |
|
132,263 | 2009-04-14 | 0 | |
WOOLF BRIAN PRESIDENT - LANE BRYANT |
|
20,000 | 2009-01-23 | 0 |
|
122,222 | 2008-12-19 | 0 | |
|
53,187 | 2008-07-11 | 0 | |
DESABATO ANTHONY A EVP - CORP. & LABOR RELATIONS |
|
115,022 | 2007-03-26 | 0 |
SPECTER ERIC M EVP - CHIEF FINANCIAL OFFICER |
|
186,577 | 2007-03-26 | 0 |
STERN COLIN D EVP, GENERAL COUNSEL & SEC. |
|
127,500 | 2007-03-26 | 0 |
SULLIVAN JOHN J VP - CONTROLLER |
|
68,647 | 2007-03-26 | 0 |
BARON JOSEPH M EVP/CHIEF OPERATING OFFICER |
|
189,341 | 2007-03-26 | 0 |
VARMA GALE H EVP - HUMAN RESOURCES |
|
103,689 | 2007-03-26 | 0 |
BOURLON MICHEL EVP-SOURCING |
|
71,906 | 2007-03-26 | 0 |
BLOISE JAMES G EVP SUPPLY CHAIN, TECH. & BSC |
|
87,653 | 2007-03-26 | 0 |
BERN DORRIT J PRESIDENT & CEO |
|
1,172,612 | 2007-02-08 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 22:15:03 UTC | 4.5296 | 0.2904 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 21:45:03 UTC | 4.5294 | 0.2906 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 21:15:03 UTC | 4.5294 | 0.2906 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 20:45:03 UTC | 4.5294 | 0.2906 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 20:15:04 UTC | 4.5294 | 0.2906 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 19:45:03 UTC | 4.5294 | 0.2906 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 19:15:04 UTC | 4.5294 | 0.2906 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 18:45:04 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 18:15:03 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 17:45:03 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 17:15:03 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 16:45:03 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 16:15:03 UTC | 4.5285 | 0.2915 | 1900000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 15:45:03 UTC | 4.5285 | 0.2915 | 1900000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 15:15:03 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 14:45:03 UTC | 4.5285 | 0.2915 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 14:15:03 UTC | 4.5285 | 0.2915 | 1900000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 13:45:03 UTC | 4.2919 | 0.2781 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 13:15:04 UTC | 4.2919 | 0.2781 | 2100000 |
COHERUS BIOSCIENCES INC CHRS | 2023-03-24 12:45:03 UTC | 4.2919 | 0.2781 | 2100000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Morningstar Funds Trust- Morningstar Alternatives Fund | CHRS | -33811.0 shares, $-294155.7 | 2022-10-31 | N-PORT |
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund | CHRS | -117790.0 shares, $-1024773.0 | 2022-10-31 | N-PORT |
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund | CHRS | -34107.0 shares, $-233974.02 | 2022-11-30 | N-PORT |
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund | CHRS | -5301.0 shares, $-41983.92 | 2022-12-31 | N-PORT |
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund | CHRS | -25900.0 shares, $-205128.0 | 2022-12-31 | N-PORT |
Guidestone Funds- Strategic Alternatives Fund | CHRS | -11947.0 shares, $-94620.24 | 2022-12-30 | N-PORT |
LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio | CHRS | -25647.0 shares, $-203124.24 | 2022-12-31 | N-PORT |
JNL Series Trust- JNL Multi-Manager Alternative Fund | CHRS | -69872.0 shares, $-553386.24 | 2022-12-31 | N-PORT |
Congress Person | Party | Chamber | Filing | Filing Date | Transaction Date | Security Type | Owner | Transaction | Amount | |
---|---|---|---|---|---|---|---|---|---|---|
Hon. Shri Thanedar | House | Filing | 2023-01-30 | 2023-01-23 | S | $15,001-$50,000 |